Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2010
06/23/2010CN1800169B Pemetrexed disodium key intermediate and its synthesis method, and method for synthesizing pemetrexed disodium from the said intermediate
06/23/2010CN1765897B Lactochrome fermentation liquor extraction process
06/23/2010CN1688194B 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
06/23/2010CN1680380B Method for production of halogen-containing phthalocyanine compound
06/23/2010CN101754968A Substituted imidazopyridazines as PI3K lipid kinase inhibitors
06/23/2010CN101747335A N-bridged Quaterrylene derivatives and preparation method thereof
06/23/2010CN101048410B HIV inhibiting bicyclic pyrimidine derivatives
06/22/2010US7741483 2-[2-ethoxyl-5-(4-ethylpiperazinyl-1-sulfonyl)phenyl]-5-methyl-7-n-propyl-3,7-dihydropyrrolo[2,3-d]pyrimidin-4-one, used for the treatment and/or prevention of sexual disorders such as erectile dysfunction
06/22/2010US7741355 Small-molecule modulators of TRP-p8 activity
06/22/2010US7741350 Bicyclic pyrazolo-heterocycles
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741333 (3-bromophenyl)-(3,3-dioxo-2,3-dihydro-1H-3 lambda 6-thia-6,8-diazacyclopenta[a]naphthalen-9-yl)amine, uses as inhibitors of protein kinases
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741330 1-((S)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pyrrolidin-1-yl)-2,3-dihydroxypropan-1-one, used for the treatment of autoimmune diseases, inflammatory diseases, allergy disorders, B-cell proliferative disorders, or thromboembolic disorders
06/22/2010US7741324 Imidazotriazines as protein kinase inhibitors
06/22/2010US7741319 11-hydroxy-5h-pyrrolo[2,1-c][1,4] benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
06/22/2010US7741318 used for treating central nervous system diseases such as depression, cognitive diseases and neurodegenerative diseases such as Parkinson's disease, alzheimer's disease or psychoses, and stroke
06/22/2010US7741102 Surface enhanced (resonance) Raman scattering with 2,4,6-trinitrostyryl-1H-benzotriazole; for detection of explosives and drugs; drug screening
06/22/2010US7740954 Reacting an unsaturated group in a chemoselective manner to form a less unsaturated group to modify a dendron intended to form a dendrimer; organic light emitters (OLED); using dendrons that contain acetylene and vinylene links between branching points and further reacting them
06/22/2010CA2579915C Indole derivatives and their use as inhibitors of p53-mdm2 interaction
06/22/2010CA2500575C New derivatives of 4-oxo-4,6,7,8-tetrhydro-pyrrolo[1,2-a]pyrazine-6-carbonxamides, their preparation process and the pharmaceutical compositions that contain them
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2408591C Process for the preparation of cyclopropyl carboxylic acid esters and derivatives
06/22/2010CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/17/2010WO2010068838A2 PROCESSES FOR PREPARING 5,7 DIAMINOPYRAZOLO[1,5-α] PYRIMIDINE COMPOUNDS
06/17/2010WO2010068810A2 Certain substituted amides, method of making, and method of use thereof
06/17/2010WO2010068806A1 Amide derivatives as btk inhibitors in the treatment of allergic, autoimmune and inflammatory disorders as well as cancer
06/17/2010WO2010068708A2 3'-azido purine nucleotide prodrugs for treatment of viral infections
06/17/2010WO2010068520A2 Substituted imidazoheterocycle derivatives
06/17/2010WO2010068483A2 Mlk inhibitors and methods of use
06/17/2010WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
06/17/2010WO2010067888A1 Dihydropyrimidopyrimidine derivatives
06/17/2010WO2010067886A1 Dihydropyrimidopyrimidine derivative
06/17/2010WO2010067594A1 Hexahydropyrroloindole derivative
06/17/2010WO2010067233A1 1,2,4 triazolo [4, 3 -a] [1,5] benzodiazepin-5 (6h) -ones as agonists of the cholecystokinin-1 receptor (cck-ir)
06/17/2010WO2010067123A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010WO2010067008A2 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010066684A2 Pyridyloxyindoles Inhibitors of VEGF-R2 and Use Thereof for Treatment of Disease
06/17/2010WO2010066629A2 Novel azaindoles
06/17/2010WO2010039187A3 Fused diimidazodiazepine compounds and methods of use and manufacture thereof
06/17/2010WO2010007116A3 Pyridons as pdk1 inhibitors
06/17/2010WO2009060197A8 Imidazopyridazines for use as protein kinase inhibitors
06/17/2010US20100152446 Piperidine Derivatives
06/17/2010US20100152264 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
06/17/2010US20100152233 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152232 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152206 Bicyclic Dihydropyrimidines and Uses Thereof
06/17/2010US20100152205 Cxcr2 inhibitors
06/17/2010US20100152198 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia
06/17/2010US20100152196 Novel Fused Pyrrolocarbazoles
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152163 Azepino[4,5-b]indoles and methods of use
06/17/2010US20100152159 Imidazopyrazine syk inhibitors
06/17/2010US20100152157 6-CYCLOAMINO-3-(PYRIDAZIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND DERIVATIVES THEREOF PREPARATION AND THERAPEUTIC APPLICATION THEREOF
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100148162 Compound for organic electroluminescent device and organic electroluminescent device
06/17/2010CA2746701A1 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010CA2745970A1 Dihydropyrimidopyrimidine derivative
06/17/2010CA2745959A1 Dihydropyrimidopyrimidine derivatives
06/17/2010CA2745922A1 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
06/17/2010CA2745063A1 2- (piperidin-1-yl) -4-heterocyclyl-thiazole-5-carboxylic acid derivatives against bacterial infections
06/17/2010CA2744498A1 Mlk inhibitors and methods of use
06/16/2010EP2196467A1 Process and apparatus for preparing metal or nonmetal phthalocyanine
06/16/2010EP2196205A1 Topoisomerase poisons
06/16/2010EP2195322A1 Imidazoý1,2-a¨pyrimidine derivatives for treating diseases such as diabetes
06/16/2010EP2195320A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors
06/16/2010EP2195316A1 Activators and therapeutic applications thereof
06/16/2010EP2035379B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/16/2010EP2010536B1 Imidazo [1, 2-b]pyridazines, their processes of preparation and their use as gaba receptor ligands
06/16/2010EP1791543B1 Triazolophthalazines
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1863806B 4-biphenylsubstituted pyrazolidin-3,5-dione derivatives
06/16/2010CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
06/16/2010CN1771040B Remedy for diabetes.
06/16/2010CN1694871B Imidazolopyridines and methods of making and using the same
06/16/2010CN101735228A 5-(4-phenoxyacetic acid)-10,15,20-triphenyl zinc porphyrin and preparation method thereof
06/16/2010CN101735227A Water-soluble N-confused porphyrin sulfonate and synthesizing method thereof
06/16/2010CN101735226A Method for preparing urotropin by ammoxidation of methanol in presence of vanadium compound catalyst
06/16/2010CN101735225A Method for converting mesaconitine into 8-butyryl-benzoyl original mesaconitine
06/16/2010CN101735224A Method for synthesizing triethylene diamine by using ethanolamine
06/16/2010CN101735223A Piperazine ketone-nitrogen heterocyclic compound and synthesis method
06/16/2010CN101735222A Pyrrole-nitrogen heterocyclic tropone compound and application thereof as protein-tyrosine-phosphatase 1 B inhibitor
06/16/2010CN101735221A Diaryl-1,2,4-triazole [4,3-a] pyrimidine heterocyclic compound, preparation method and application thereof
06/16/2010CN101735220A Crystal form of 6, 7-dihydro-6-mercapto-5H-pyrazolo[1,2-alpha][1,2,4] triazoliumchloride and preparation method thereof
06/16/2010CN101735075A Method for ammoxidation from methanol into hyamine
06/16/2010CN101250189B Bisfatty amido substituted quinazolone derivatives as well as preparation method and use thereof as anti-cancer drugs
06/16/2010CN101235035B Method for preparing tetramethoxymethylglycoluril
06/16/2010CN101115756B Tetracyclic imidazo-benzodiazepines as GABA receptors modulators
06/16/2010CN101044145B Imidazo-benzodiazepine derivatives
06/15/2010US7737284 chemical condensation process to produce a chemical intermediates for antitumor agents; industrial scale, and provide good yields; simplification; efficiency
06/15/2010US7737272 Diazaphosphacycle transition metal complexes
06/15/2010US7737271 IR absorbing dyes is compatible with inkjet printers, inks, lightfastness, thermal stability, nontoxic, low-cost manufacture
06/15/2010US7737270 reacting phthalonitrile with cuprous chloride or titanium tetrachloride in ethanol to form titanyl or copper phthalocyanine; efficiency; pollution control
06/15/2010US7737156 6-(Cyclohexylmethyl)-1-(1-ethylpropyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, administered to humans or animals, to improve perception, concentration, cognition, learning and/or memory, as a consequence of dementia, stroke, brain trauma, Alzheimer's disease, Parkinson's disease or depression
1 ... 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 ... 573